CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-02 | Hussain Abbas Director | Grant or award · Stock Option (Right to Buy) | +8,093 | 8,093 | ||
| 2024-10-02 | Hussain Abbas Director | Grant or award · Stock Option (Right to Buy) | +5,100 | 5,100 | ||
| 2024-10-02 | Hussain Abbas Director | Grant or award · Restricted Stock Units | +1,439 | 1,439 | ||
| 2024-10-02 | Hussain Abbas Director | Grant or award · Restricted Stock Units | +892 | 892 | ||
| 2024-09-09 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −551 | $73.57 | $41K | 18,154 |
| 2024-09-06 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +1,139 | 18,705 | ||
| 2024-09-06 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,139 | 3,416 | ||
| 2024-09-03 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −114 | $76.99 | $9K | 17,566 |
| 2024-09-03 | Hoge Stephen President | Sale 10b5-1 | −318 | $76.99 | $24K | 1,443,002 |
| 2024-08-30 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +233 | 17,680 | ||
| 2024-08-30 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −233 | 1,396 | ||
| 2024-08-30 | Hoge Stephen President | Exercise or conversion 10b5-1 | +652 | 1,443,320 | ||
| 2024-08-30 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −652 | 3,910 | ||
| 2024-08-29 | Mock James M Chief Financial Officer | Sale 10b5-1 | −162 | $78.03 | $13K | 8,767 |
| 2024-08-29 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −162 | $78.03 | $13K | 17,447 |
| 2024-08-29 | Hoge Stephen President | Sale 10b5-1 | −300 | $78.03 | $23K | 1,442,668 |
| 2024-08-28 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +329 | 8,929 | ||
| 2024-08-28 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −329 | 3,288 | ||
| 2024-08-28 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +329 | 17,609 | ||
| 2024-08-28 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −329 | 3,288 |
Page 23 of 38 · 743 trades